Tesla stock declined on Monday, underperforming the broader market as investors digested fresh developments around the company’s supply chain and regulatory scrutiny, even as the stock remains sharply higher for the year.Shares of Tesla were…
Category:
Investing
-
-
Lululemon Athletica (NASDAQ: LULU) is in focus today after its founder, Chip Wilson, reignited tensions with the company’s leadership – announcing a proxy battle aimed at reshaping the board.Wilson’s announcement comes only days after the…
-
Precious metals fell sharply on Monday as investors resorted to booking profits after steep gains in the last few weeks. Silver and platinum dropped after hitting record highs earlier in the session. Gold prices also fell more…
-
Caterpillar Inc (NYSE: CAT) has been the standout performer in the Dow Jones Industrial Average this year, with a more than 100% rally since early April.This explosive rally transformed CAT stock from a traditional industrial…
-
Warren Buffett’s Berkshire Hathaway is holding roughly $400 billion in cash and Treasury equivalents, the largest idle war chest in corporate history.That’s not merely prudence. When the world’s most successful value investor refuses to deploy…
-
The market performance of altcoins during 2025 followed Bitcoin because investors chose to invest in digital assets that operated under established frameworks and demonstrated practical applications.The TradingView data shows Bitcoin experienced a 7% year-to-date decline…
-
Analysts predict packaged food manufacturers and fast-food eateries may be pushed to alter more of their goods next year when newly licensed appetite-suppressing GLP-1 tablets become accessible in January 2026. The decision comes as more…
-
US stocks held steady on Christmas Eve, with the broad market opening virtually flat.The Dow edged marginally higher, while the Nasdaq Composite matched the S&P’s sluggish performance in a shortened trading session marked by thin…
-
Shares of Agios Pharmaceuticals surged nearly 15% in premarket trading on Wednesday after the US Food and Drug Administration approved an expanded use of its drug mitapivat, strengthening investor optimism around the company’s growth prospects.The…
-
Nvidia stock (NASDAQ: NVDA) tumbled nearly 1% on Wednesday after reports surfaced that the AI chipmaker has paused testing of Intel’s ambitious 18A manufacturing process.The move marks a significant setback for Intel’s foundry revival strategy…